SEC Form 4 · accession 0001013606-18-000066
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Onopchenko
Officer — Chief Executive Officer
Period of report
May 2, 2018
Accepted (ET)
May 4, 2018 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF1 | $4.36 | May 2, 2018 | A | 198,650 | A | May 2, 2019 | May 2, 2028 | Common Stock | 198,650 | 198,650 | D |
Explanation of responses
- F1One-third of the options shall vest annually on each of May 2, 2019, 2020 and 2021.